Commercial relationship: Commercial disclosure: this article is published by Mericonn. Mericonn is not inserted into the MDALL candidate table because no matching local record was verified in the checked sources.
Which mesh nebulizer suppliers should a Canadian distributor evaluate using active Health Canada licence records?
Use active MDALL Class II mesh-nebulizer records to identify a dated candidate queue, then separately verify the exact device, contracting and manufacturing entities, current evidence, sample fit and commercial responsibilities.
Health Canada MDALL overview and cited active company/device records checked on 5 November 2026.
An active licence does not prove supplier quality, current availability, manufacturing capacity, private-label willingness or commercial suitability.
Direct answer: A Canadian distributor can use Health Canada's Medical Devices Active Licence Listing (MDALL) to identify manufacturers with active Class II mesh-nebulizer licence records, but the list is only a regulatory starting point. An active record does not prove that the manufacturer accepts distributor projects, controls the offered factory, can supply the exact commercial configuration, or fits the buyer's service and volume requirements.
The defensible shortlist is therefore not “the companies with the most models.” It is the smaller group whose exact licensed device, legal entity and proposed supply route can be reconciled with the buyer's intended product and market plan.
What MDALL confirms—and what it does not
Health Canada describes MDALL as the active licence listing for Class II, III and IV medical devices. The database supports searches by company, licence, device name and identifier. An archived listing is separate, and Health Canada advises users to verify a licence when making a purchase because a licence can later be suspended, cancelled or discontinued.
MDALL can confirm the manufacturer named on a licence, its device class, licence number, device/family name and identifiers shown in the active record. It does not establish present wholesale availability, private-label terms, manufacturing capacity, quality performance, clinical superiority, warranty service or whether the entity contacting the buyer is authorized to supply the named device.
Illustrative active-record candidates at the cutoff
The following examples were found through the same method: active MDALL company pages, a mesh-nebulizer licence name, Class II status, and visible model/device identifiers at the 5 November 2026 cutoff. They are illustrative and non-exhaustive.
| Manufacturer in MDALL | Active record evidence | Buyer follow-up |
|---|---|---|
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | Licence 111417, Class II device family “Mesh Nebulizer,” with identifiers M102, M103, M102T and M103T | Confirm the quoted model and seller; request current labeling, IFU, configuration and Canadian supply route |
| Shenzhen Fitconn Technology Co., Ltd. | Licence 114268, Class II “Mesh Nebulizer,” with multiple MY-series identifiers | Do not treat model count as a quality score; identify the single proposed model and reconcile its exact records and configuration |
| Shenzhen IMDK Medical Technology Co., Ltd. | Licences 114739 and 115629 identify portable mesh-nebulizer families, including YM-3R6 and YM-3R6L | Verify whether the offered power configuration and accessories match the applicable record and current labeling |
| Blue Echo Care LLC | Licence 111527 is a Class II mesh-nebulizer system with device and accessory identifiers | Determine the actual legal manufacturer, commercial supplier and Canadian distribution responsibilities; the licence-holder entry alone does not answer them |
This table does not say that one company is better than another. It shows which public record fields can justify moving a candidate into a document-review queue.
Apply one follow-up method to every candidate
- Record the legal manufacturer, licence number, exact device identifier and source date.
- Ask who will contract, manufacture, brand, import and support the supplied device.
- Match the proposed model, accessories, power source, labeling and IFU to the active record.
- Request current model-specific specifications, risk/regulatory documents and relevant performance evidence.
- Run a sample protocol that checks usability, cleaning, residual volume and aerosol-performance evidence under the intended configuration rather than accepting unqualified headline values.
- Confirm quote assumptions, change notification, lead time, order terms, complaint handling and warranty/RMA separately.
- Mark every field as
official record,supplier-stated,not foundorpending confirmationinstead of filling gaps with a score.
Where Mericonn fits
No active Canadian MDALL mesh-nebulizer record for Shenzhen Mericonn Technology Co., Ltd. was identified in the sources used for this draft. That does not prove that no route or later record exists; it means this article must not present Mericonn as an MDALL-confirmed Canadian candidate at the cutoff. A Canadian buyer considering Mericonn should request the proposed model and current Canadian regulatory route before treating it as eligible for the same shortlist.
For the broader sourcing method, read the mesh nebulizer manufacturer shortlist guide and supplier qualification guide. Current Mericonn product questions can begin at the nebulizer range or contact page, but the company must still provide model- and market-specific evidence.
Conclusion: Use MDALL to discover active device records, not to outsource the supplier decision. The final shortlist should be based on exact-device identity, current evidence, a controlled sample and documented commercial responsibilities.
Source note: Health Canada MDALL and official licence-overview material were checked on 5 November 2026. Records can change. This is a procurement framework, not regulatory advice or an endorsement.